Search Result "neurodegenerative and neuropsychiatric diseases"


Aquaporins and Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 8 Issue: 2 Year: 2010 Page: 112-121
Author(s): Eleonora Foglio, Rodella Luigi Fabrizio

Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2746-2763
Author(s): W.-Y. Ong, T. Farooqui, A.A. Farooqui

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 1 Year: 2010 Page: 120-127
Author(s): Sarah Burgess, Valentina Echeverria

Huntingtons Disease: The Value of Transcranial Meganetic Stimulation

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2482-2491
Author(s): F.J. Medina, I. Tunez

New Therapeutic Strategy for Parkinsons and Alzheimers Disease

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2764-2774
Author(s): E. Esposito, S. Cuzzocrea

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5 Issue: 3 Year: 2010 Page: 182-194
Author(s): Mariacristina Siotto, Serena Bucossi, Rosanna Squitti

Expression and Functions of LRP-2 in Central Nervous System: Progress in Understanding its Regulation and the Potential Use for Treatment of Neurodegenerative Diseases

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 10 Issue: 4 Year: 2010 Page: 249-254
Author(s): Carlos Spuch, Carmen Navarro

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 2799-2817
Author(s): Makoto Naoi, Wakako Maruyama

Pharmacological Therapy of Parkinsons Disease: Current Options and New Avenues

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5 Issue: 3 Year: 2010 Page: 221-238
Author(s): Nicola Simola, Annalisa Pinna, Sandro Fenu

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 6 Year: 2010 Page: 791-800
Author(s): Mathuravani A. Thevandavakkam, Robert Schwarcz, Paul J. Muchowski, Flaviano Giorgini

Previous   Next

Go To   Results 1 - 1 of 71

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy